Rate My Professor Michael Repka

Dr. Repka specializes in pediatric ophthalmology, strabismus, retinopathy of prematurity, and pediatric neuro-ophthalmology, with clinical interests in amblyopia management using alternatives to patching, strabismus surgery with botulinum toxin and adjustable sutures, and pediatric cataract surgery. He chaired the Pediatric Eye Disease Investigator Group from 1997 to 2009, leading over 20 clinical trials, and served as Clinical Center Principal Investigator for the Cryotherapy for Retinopathy of Prematurity trial. His highly cited publications include 'Incidence and early course of retinopathy of prematurity' (Ophthalmology, 1991), 'A randomized trial of patching regimens for treatment of moderate amblyopia in children' (Archives of Ophthalmology, 2003), 'Randomized trial of treatment of amblyopia in children aged 7 to 17 years' (Archives of Ophthalmology, 2005), and 'Prevalence of amblyopia and strabismus in white and African American children aged 6 through 71 months' (Ophthalmology, 2009). Dr. Repka is Associate Editor of Ophthalmology journal, has served on editorial boards including Journal of AAPOS and British Journal of Ophthalmology, and chaired the FDA Dermatologic and Ophthalmic Drugs Advisory Committee. He is President of the American Academy of Ophthalmology for the 2025 term, past President of the American Association for Pediatric Ophthalmology and Strabismus, and has received the AAO Life Achievement Award (2011), AAPOS Lifetime Achievement Award (2008), and multiple honor awards from both organizations, along with the Frank Costenbader and Eugene Helveston Lectures.